Literature DB >> 29143361

2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological Activity.

Pierre Koch1, Francesco Ansideri1.   

Abstract

2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles represent an important class of ATP-competitive protein kinase inhibitors, offering the possibility of multiple interactions with different regions of the target enzyme. The necessity of exploring the effects of diverse chemical decorations around the imidazole core prompted the design of several synthetic routes aimed at achieving both efficiency and flexibility. Additionally, the optimization of established protocols and the extensive use of transition metal-catalyzed cross-coupling reactions have been broadening the spectrum of preparative methodologies within the last decade. This review summarizes the progress in the development of synthetic strategies leading to 2-alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles and 1-alkyl-2-alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles and offers a glance at the biological activities of this class of compounds.
© 2017 Deutsche Pharmazeutische Gesellschaft.

Entities:  

Keywords:  1,2,4,5-Tetra-substituted imidazoles; 2,4,5-Tri-substituted imidazoles; Kinase inhibitors; Regioselective synthesis

Mesh:

Substances:

Year:  2017        PMID: 29143361     DOI: 10.1002/ardp.201700258

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  A Diverse and Versatile Regiospecific Synthesis of Tetrasubstituted Alkylsulfanylimidazoles as p38α Mitogen-Activated Protein Kinase Inhibitors.

Authors:  Francesco Ansideri; Stanislav Andreev; Annette Kuhn; Wolfgang Albrecht; Stefan A Laufer; Pierre Koch
Journal:  Molecules       Date:  2018-01-20       Impact factor: 4.411

2.  Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3.

Authors:  Francesco Ansideri; Joana T Macedo; Michael Eitel; Ahmed El-Gokha; Dhafer S Zinad; Camilla Scarpellini; Mark Kudolo; Dieter Schollmeyer; Frank M Boeckler; Bärbel S Blaum; Stefan A Laufer; Pierre Koch
Journal:  ACS Omega       Date:  2018-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.